Iraq vs Mali: The number of people with susceptibility test result for rifampicin
Iraq
29.8
in 2021
Mali
26.76
in 2021
Iraq rank
133rd
Mali rank
134th
The number of people with susceptibility test result for rifampicin over time
- Iraq
- Mali
How they compare
Iraq currently reports 29.8 against 26.76 in Mali, a difference of 3.04.
That makes Iraq's figure about 1.1 times Mali's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Iraq ahead.
Iraq ranks 133rd and Mali ranks 134th of 146 countries.
Across the 2 decades both report, Iraq averaged higher in 1 and Mali in 1.
Head to head by decade
| Decade | Iraq | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 89.53 | 3.3 | 86.23 | Iraq |
| 2020s | 18.21 | 40.18 | 21.97 | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Iraq or Mali?
- Iraq, at 29.8 against 26.76 in Mali as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Iraq and Mali?
- 3.04, with Iraq ahead.
- How many years of comparable data are there for Iraq and Mali?
- 5 years are reported by both, from 2017 to 2021.
- How do Iraq and Mali rank globally for the number of people with susceptibility test result for rifampicin?
- Iraq ranks 133rd and Mali ranks 134th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.